Vimarsana
Biggest News Aggregation in the World

Therapy Designed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapy Designed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapy Designed Today - Breaking & Trending Today

Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - Vimarsana News

Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Published: April 22, 2024

Preclinical findings showed robust anti-tumor activity of ADI-270 in multiple CD70-positive solid and hematological cancer models ADI-270 demonstrated enhanced functional potency and resilience in...

Source: marketscreener.com
Related Topics:
Blake AftabAdicet BioAdicet Bio IncDrug AdministrationExchange CommissionAnnual MeetingTargeted GeneCell TherapyChief Scientific OfficerTherapy DesignedMultiple SolidHematological Cancer IndicationsAshon GreenPrivate Securities Litigation Reform Act
Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR) - Vimarsana News

Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR)

Published: September 11, 2023

- Arrowhead Expands the Reach of RNAi Therapies to Address Diseases in the Lung - Late-Breaking Clinical Data for ARO-RAGE for Treatment of Asthma Demonstrate Deep and Durable Gene Silencing - Promising Preclinical

Source: benzinga.com
Related Topics:
International CongressArrowhead PharmaceuticalsSubcutaneous Administration Mediates PulmonaryEuropean Respiratory SocietyArrowhead Pharmaceuticals IncEuropean Respiratory Society International CongressAddress DiseasesBreaking Clinical DataAsthma Demonstrate DeepDurable Gene SilencingEuropean Respiratory Society InternationalJavier San MartinPulmonary Inflammation Mediates DurableNonhuman PrimatesTherapeutics Delivery Platform CompatibleFirst In Human StudyTherapy DesignedSilence PulmonaryBreaking AbstractTherapeutic CandidateHuman Lung TissueHarbor StatementPrivate Securities Litigation Reform Act
Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences - Vimarsana News

Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences

Published: September 1, 2023

Arrowhead Pharmaceuticals, Inc. today announced that it is scheduled to participate in the following upcoming events: Citi’s 18th Annual BioPharma Conference – September 6, 2023 Type: 1-on-1...

Source: marketscreener.com
Related Topics:
Arrowhead PharmaceuticalsSubcutaneous Administration Mediates PulmonaryExchange CommissionArrowhead Pharmaceuticals IncMorgan StanleyEuropean Respiratory SocietyInternational CongressAnnual Biopharma ConferenceRespiratory SocietyPoster SessionClinical Stage InhaledPulmonary Inflammation Mediates DurableNonhuman PrimatesTherapeutics Delivery Platform CompatibleLate Breaking AbstractFirst In Human StudyTherapy DesignedSilence PulmonaryTherapeutic CandidateHuman Lung TissueHealthcare ConferenceFireside Chat PresentationAnnual Global Healthcare ConferenceFitzgerald Global Healthcare ConferenceHarbor Statement